Compound information
- Natural Products
- ZC1570600
- Molecular Formula
- C22H26N4O6
- Molecular Weight
- 442.185234552 g/mol
- Structure
-
- IUPAC Name
- (2S)-2-(benzyloxycarbonylamino)-5-[(N-benzyloxycarbonylcarbamimidoyl)amino]pentanoic acid
- InChI
- InChI=1S/C22H26N4O6/c23-20(26-22(30)32-15-17-10-5-2-6-11-17)24-13-7-12-18(19(27)28)25-21(29)31-14-16-8-3-1-4-9-16/h1-6,8-11,18H,7,12-15H2,(H,25,29)(H,27,28)(H3,23,24,26,30)/t18-/m0/s1
- InChI Key
- YWMQITGDXCEQSI-SFHVURJKSA-N
- SMILES
- N=C(NCCC[C@H](NC(=O)OCc1ccccc1)C(=O)O)NC(=O)OCc1ccccc1
- Source
- ZINC000032225246
Warheads
- Carbamate
-
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 32 | Ring Count | 2 |
Heteroatom Count | 10 | Rotatable Bond Count | 10 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 5 |
Topological Polar Surface Area | 149.84 Å2 | LogP | 2.316 |
LogS | -3.394 | LogD | 2.078 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.0 | Pgp substrate | 0.023 |
HIA | 0.001 | F20 % | 0.963 |
F30 % | 0.007 | Caco-2 | -6.507 |
MDCK | -5.655 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.289 | PPB | 88.536 |
VD | 0.466 | Fu | 0.782 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.16 | CYP1A2 substrate | 0.685 |
CYP2A6 substrate | 0.409 | CYP2B6 substrate | 0.594 |
CYP2C19 inhibitor | 0.279 | CYP2C19 substrate | 0.81 |
CYP2C8 substrate | 0.807 | CYP2C9 inhibitor | 0.689 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.566 |
CYP2D6 substrate | 0.878 | CYP2E1 substrate | 0.412 |
CYP3A4 inhibitor | 0.053 | CYP3A4 substrate | 0.979 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.778 | CL | 0.806 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.018 | Hepatotoxicity | 0.166 |
Mutagenicity | 0.235 | Rat Oral Acute Toxicity | 0.114 |
FDAMDD | 0.145 | Skin Sensitization | 0.039 |
Carcinogenicity | 0.0 | Eye Corrosion | 0.003 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.343 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.363 | IGC50 | 2.591 |
LC50FM | 3.922 | LC50DM | 5.113 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.37 | NR-AR-LBD | 0.268 |
NR-AhR | 0.006 | NR-Aromatase | 0.028 |
NR-ER | 0.294 | NR-ER-LBD | 0.332 |
NR-PPAR-gamma | 0.441 | SR-ARE | 0.07 |
SR-ATAD5 | 0.405 | SR-HSE | 0.124 |
SR-MMP | 0.007 | SR-p53 | 0.034 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.